Albany, New York, 04 May 2015 : Increasing prevalence of diabetes and upsurge in the number of lifestyle-related conditions such as obesity are augmenting the growth of the global human insulin market. To explore this and many more trends further, Market Research Reports Search Engine (MRRSE) has added a new report titled ‘‘ Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020” to its repository. The report, published by Persistence Market Research, covers the present status and forthcoming trends and opportunities in the market for human insulin. The report also offers much information besides in the form of descriptive tables and analytical graphs.

1. Human Insulin Market to Develop at a CAGR Of 12.4%
from 2014 to 2020 Owing to Expanding Predominance of
Diabetes and Spiraling Number of Lifestyle Disorders
Published By:
Persistence Market
Research
Contact US:
Tel: +1-518-618-1030
Email: sales@mrrse.com
Toll Free : 866-997-4948 (US-
CANADA)

2. Report Description
Diabetes refers to a group of metabolic disease characterized by high blood sugar level. It occurs due to
inadequate secretion of insulin inside the pancreas. Some of the common symptoms for diabetes are
frequent urination, excessive thirst, increased hunger, weight loss and tiredness. Type 1, type 2 and
gestational diabetes are three common types of diabetes. Type 1 diabetes is an autoimmune disease
occurred due to high blood glucose level whereas, type 2 diabetes is a lifelong chronic disease caused due
to excess secretion of insulin inside the body.
As per the Centers for Diseases Control and Prevention (CDC), a U.S.-based national public health
establishment, more than 33% kids and teenagers were obese in 2012 in the U.S. This bears out the
importance of diabetes and the various conditions associated with it on the human insulin market. In the
global perspective, strict administrative prerequisites for medication approval and uneven pricing and
constrained access to human insulin in developing nations are controlling the development of the human
insulin market.
Complete Report with TOC @ http://www.mrrse.com/human-insulin-market

3. Scope
As per this report, the global human insulin market had a total value of US$24,332.6 million in 2014 and is
predicted to develop at a CAGR of 12.4% between 2014 and 2020, reaching US$49,197.3 million by 2020.
The human insulin market is segmented on the basis of the type of diseases, insulin, and geography.
North America has the largest market and Asia-Pacific has the fastest growing market for human insulin.
In terms of type of human insulin, modern human insulin represents the largest and fastest growing
segment of this market.

4. Key Players
Some of the major players in the human insulin market are Novo Nordisk A/S, Eli Lilly and Company,
Sanofi, Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc.,
Wockhardt and others.
Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/162

5. Corporate Office
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@mrrse.com
Toll Free : 866-997-4948 (US-CANADA)
Contact Us
Read More @ http://www.mrrse.com/